Eds-flu versus traditional nasal steroids for treating chronic rhinosinusitis: summarizing current evidence for symptom benefits

Standard intranasal steroids (INS) are first-line therapy, but yield limited benefit, in treating defining symptoms of CRSw/sNP (congestion, rhinorrhea, facial pain/pressure, anosmia). We compared symptom relief with traditional INS, as summarized in a 2016 Cochrane review, with symptom relief reported in pooled trials with EDS-FLU (exhalation delivery system with fluticasone).
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: A452 Source Type: research